Tag: stent
Terumo Aortic announces launch of global Thoraflex Hybrid EXTEND study
Terumo Aortic announced in a press release the launch of the company’s global post-approval study (PAS) known as EXTEND for Thoraflex Hybrid, the only...
First patient enrolled in Merit Medical’s WRAPSODY registry study
Merit Medical has announced the successful enrolment of the first patient in its WRAP registry study in a press release. This study will evaluate...
Boston Scientific announces agreement to purchase majority stake of M.I.Tech from...
M.I.Tech is the creator of the HANAROSTENT technology, a family of conformable, non-vascular, self-expanding metal stents, which have been distributed by Boston Scientific in...
Terumo Aortic announces US FDA approval for Thoraflex Hybrid device
Terumo Aortic has announced that the US Food and Drug Administration (FDA) has granted approval of the Thoraflex Hybrid frozen elephant trunk (FET) device...
VIVO 12-month results show “very good early success, excellent safety and...
Anthony Comerota (Alexandria, USA), global principal investigator of the VIVO trial, discusses the highlights of the 12-month results of the VIVO clinical study that...
Dynetic-35 balloon expandable cobalt chromium iliac stent system gains CE mark
Dynetic-35, the balloon-expandable cobalt chromium iliac stent system from Biotronik, is now commercially available in Europe. Indicated for the treatment of de novo or...
CIRSE 2019: Hear the latest from clinical trials comparing paclitaxel technologies...
NOTE: ONLY intended for healthcare professionals outside of the USA and France.
Zoom in on a tête-à-tete between Marianne Brodmann (Graz, Austria) and Giovanni Torsello...
Experts discuss latest results from EFFPAC and TINTIN trials presented at...
NOTE: ONLY intended for healthcare professionals outside of the USA.
Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the...
Eluvia outperforms Zilver PTX in IMPERIAL 12-month results
The Eluvia drug-eluting vascular stent system (Boston Scientific) shows superior primary patency compared to the Zilver PTX drug-eluting stent (Cook Medical), concludes the 12-month...
Full US availability of Biotronik Pulsar-18 self-expanding stent announced
Getinge has announced the full US market release of the Pulsar-18 stent from Biotronik. Pulsar-18 is the only available self-expanding stent for blocked superficial...
Getinge becomes a single brand company and launches Advanta V12 32mm...
Getinge has announced that, in order to better convey its customer offering and strengthen its position, it has grouped its portfolio under one single...
Veryan Medical receives £13.5m further funding
Veryan Medical has received a further £13.5m of funding in the form of both equity and debt from its existing investors, including Touchstone Innovations,...
Five-year results confirm “long-term safety and durability” of Endologix Ovation system
Clinical data presented at the 2016 VEITH symposium (New York City, USA) of the global Ovation Pivotal Trial has revealed positive five-year safety and...
Stentys expands benefits of drug-eluting, self-expanding stent to lower limb arteries
Clinical trial found Stentys treatment prevented amputation in 99% of cases.
